Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis.
Human immunodeficiency virus type 1 (HIV-1) R5 isolates that predominantly use CCR5 as a coreceptor are frequently described as macrophage tropic. Here, we compare macrophage tropism conferred by HIV-1 R5 envelopes that were derived directly by PCR from patient tissue. This approach avoids potentially selective culture protocols used in virus isolation. Envelopes were amplified (i) from blood and semen of adult patients and (ii) from plasma of pediatric patients. The phenotypes of these envelopes were compared to those conferred by an extended panel of envelopes derived from brain and lymph node that we reported previously. Our results show that R5 envelopes vary by up to 1,000-fold in their capacity to confer infection of primary macrophages. Highly macrophage-tropic envelopes were predominate in brain but were infrequent in semen, blood, and lymph node samples. We also confirmed that the presence of N283 in the C2 CD4 binding site of gp120 is associated with HIV-1 envelopes from the brain but absent from macrophage-tropic envelopes amplified from blood and semen. Finally, we compared infection of macrophages, CD4(+) T cells, and peripheral blood mononuclear cells (PBMCs) conferred by macrophage-tropic and non-macrophage-tropic envelopes in the context of full-length replication competent viral clones. Non-macrophage-tropic envelopes conferred low-level infection of macrophages yet infected CD4(+) T cells and PBMCs as efficiently as highly macrophage-tropic brain envelopes. The lack of macrophage tropism for the majority of the envelopes amplified from lymph node, blood, and semen is striking and contrasts with the current consensus that R5 primary isolates are generally macrophage tropic. The extensive variation in R5 tropism reported here is likely to have an important impact on pathogenesis and on the capacity of HIV-1 to transmit.
Peters
Paul J
PJ
Center for AIDS Research, Program in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation St., Biotech II Suite 315, Worcester, MA 01605, USA.
Sullivan
W Matthew
WM
Duenas-Decamp
Maria J
MJ
Bhattacharya
Jayanta
J
Ankghuambom
Chiambah
C
Brown
Richard
R
Luzuriaga
Katherine
K
Bell
Jeanne
J
Simmonds
Peter
P
Ball
Jonathan
J
Clapham
Paul R
PR
D000328:Adult; D019943:Amino Acid Substitution; D001921:Brain / Q000473:pathology / Q000821:virology; D015496:CD4-Positive T-Lymphocytes / Q000473:pathology / Q000821:virology; D005260:Female; D015699:HIV Envelope Protein gp120 / Q000235:genetics / Q000378:metabolism; D015658:HIV Infections / Q000097:blood* / Q000235:genetics / Q000473:pathology / Q000635:transmission*; D015497:HIV-1 / Q000235:genetics; D006367:HeLa Cells; D006801:Humans; D007231:Infant, Newborn; D008198:Lymph Nodes / Q000821:virology*; D008264:Macrophages / Q000473:pathology / Q000821:virology; D008297:Male; D012661:Semen / Q000821:virology*; D013045:Species Specificity; D019562:Viral Load; D014771:Virion / Q000235:genetics; D014776:Virus Cultivation
D015699:HIV Envelope Protein gp120